Effect of SNF472 on Progression of Cardiovascular Calcification in End-Stage-Renal-Disease (ESRD) Patients on Hemodialysis (HD)

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 274 participants.

Also called NCT02966028

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 274 participants (enrolled count) (from the registry)
Sponsor
Sanifit Therapeutics S. A. (from the registry)
Registry
  • NCT NCT02966028
Other papers using this trial's data
  • Effects of Myo-inositol Hexaphosphate (SNF472) on Bone Mineral Density in Patients Receiving Hemodialysis: An Analysis of the Randomized, Placebo-Controlled CaLIPSO Study Clinical journal of the American Society of Nephrology : CJASN, 2021-05-08 DOI, PubMed 33835939, PMC8259477 Not in the PMC Open Access subset.
  • Slowing Progression of Cardiovascular Calcification With SNF472 in Patients on Hemodialysis: Results of a Randomized Phase 2b Study Circulation, 2020-03-03 DOI, PubMed 31707860

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Spain, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02966028. Randomized; quadruple masking; primary purpose treatment. Start 2016-11 (registry gives no type); primary completion 2019-08 (actual). Results posted on 2021-03-16.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effect of SNF472 on Progression of Cardiovascular Calcification in End-Stage-Renal-Disease (ESRD) Patients on Hemodialysis (HD)
Condition
Cardiovascular Diseases
Condition
Cardiovascular Abnormalities
Condition
Calcifications, Vascular
Condition
Endstage Renal Disease
Condition
ESRD
Condition
Coronary Artery Calcification
Intervention (Drug)
SNF472
Intervention (Drug)
Placebo
Lead sponsor
Sanifit Therapeutics S. A. (class: other)
Collaborator
Clinipace Worldwide (class: industry)

Record details

Record id
cardio:ct-nct02966028
Content hash
0a997283ef12440a499fc5decfd808b27f79c57dec32369e50f5071a8ade9e7d